CHPA praises DXM Abuse Prevention Act Report: Americans feel healthier under Affordable Care Act GAO IDs 3 ways DEA can improve communications with pharmacists, manufacturers Poll: Voters support generic drug transparency legislation NACDS comments on managed care in Medicaid, CHIP FDA and FTC to address key industry concerns at CRN Conference FDA approves new treatment for hepatitis C genotype 3 infections GPhA, Biosimilars Council pen open letter to President Obama on TPP Report: Israel allows pharmacies to dispense cannabis FDA approves Technivie for chronic hepatitis C treatment First Previous 60 61 62 63 64 Next Last